Michael J. Welsh, MD

Director, Pappajohn Biomedical Institute and the University of Iowa Cystic Fibrosis Research Center; Roy J. Carver Chair in Biomedical Research; Professor of Internal Medicine, Molecular Physiology and Biophysics, and Neurosurgery, University of Iowa; Investigator, Howard Hughes Medical Institute.

Dr. Welsh obtained an MD from and completed an internal medicine residency at the University of Iowa. He then trained in pulmonary medicine and research at the University of California, San Francisco and physiology at the University of Texas, Houston. He is an Investigator of the Howard Hughes Medical Institute.

Dr. Welsh’s research has concentrated on understanding the biology and pathogenesis of cystic fibrosis and on the development of new treatments. He is also investigating the biology of protons and acid-sensing ion channels involved in normal and pathological neuronal function. His clinical activities have focused on pulmonary diseases. He co-founded Exemplar Genetics and Emmyon.

Dr. Welsh served as president of the American Society for Clinical Investigation and the Association of American Physicians.  He received the Carver College of Medicine Second Annual Distinguished Mentor Award. He was elected to the Institute of Medicine, the American Academy of Arts and Sciences, and the National Academy of Sciences. He is a native Iowan who enjoys his native tall-grass prairie near Iowa City.

The Harrington Project for Discovery & Development

Breakthrough Medicine